Allergan Inc. (AGN) Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. (MAPP) and Intent to Exercise Top-Up Option to Effect a Short-Form Merger
3/1/2013 9:49:48 AM
More...
|
Allergan Inc. (AGN) and MAP Pharmaceuticals, Inc. (MAPP) Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino Act
2/7/2013 9:58:14 AM
More...
|
Allergan Inc. (AGN) Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. (MAPP)
1/31/2013 10:24:52 AM
More...
|
Allergan Inc. (AGN) to Buy MAP Pharmaceuticals, Inc. (MAPP) for $958 Million
1/23/2013 6:55:08 AM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) to Present at the 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 7:28:36 AM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Announces FDA Acceptance for Filing of NDA Resubmission for LEVADEX®
11/26/2012 8:46:46 AM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) to Present at Upcoming Investor Conferences
11/9/2012 2:15:18 PM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Reports Third Quarter of 2012 Financial Results
11/2/2012 9:33:35 AM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Resubmits New Drug Application to FDA for LEVADEX® Orally Inhaled Migraine Drug
10/16/2012 9:24:35 AM
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Announces Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock
8/30/2012 10:17:01 AM
More...
|
|